Xeris Pharmaceuticals Secures $41,000,000 Series C Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=afab46cf-64ab-4efd-be5d-ccefe2fc9844 - Date
1/12/2016 - Company Name
Xeris Pharmaceuticals - Mailing Address
3208 Red River Street Austin, TX 78705 USA - Company Description
Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. - Website
http://www.xerispharma.com - Transaction Type
Venture Equity - Transaction Amount
$41,000,000 - Transaction Round
Series C - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Redmile Group - Venture Investor
Deerfield Capital - Venture Investor
Sabby Capital - Venture Investor
McNair Group
